The induction and mechanism of fatty liver in the rat by the synthetic carcinogen 2-acetylaminofluorene (AAF) were investigated.
the activity of pyruvate kinase and a-glycerophosphate dehydrogenase. The AAFdosage had no effect on the incorporation of [l-14C]acetate into the lipid fraction during in vitro incubation of liver slices. The supplement of adenine to the AAFdiet had no effect on the accumulation of liver lipid.
It is suggested from the result of treatment with Triton WR-1339that a block in the secretion of triglyceride from the liver is a major cause of the induction of fatty liver by AAF.
The administration of chemical agents such as carbon tetrachloride, 2) ethionine,3) orotic acid,4) puromycin,5) or white phosphorus6) to rats causes a rise in the hepatic lipid content with the eventual development of a fatty liver.
It is generally accepted that such effects are probably the result of inhibition of triglyceride release from the liver due to a block in the plasma lipoprotein formation.
In the present study, the induction and mechanism of fatty liver in the rat by the synthetic carcinogen 2-acetylaminofluorene (AAF) were investigated. AAFis also known as an inhibitor of protein biosynthesis, which affects both the replication and transcription of DNA.7) The possibility that the inhibition of plasma lipoprotein formation in the liver can also account for this type of fatty liver is pointed out.
MATERIALS AND METHODS
Animals. Male rats of the Wistar strain weighing about 125g were used. The animals were housed in individual cages at 23+1°C in a room with a 12hr light-12hr dark cycle. Before being placed on the experimental diets, the rats were fed on a commercial stock diet (Type MF, Oriental Yeast Co., Ltd., Tokyo). The composition of the experimental diets is shownin Table I . The rats were fed on the experimental diet, which were kneaded with tap water, and water ad libitum. Body weight and food intake were recorded during the experimental period. After 3 weeks on these experimental diets, the rats were stunned by a sharp blow on the head and decapitated. The liver was removed as rapidly as possible and lyophilized.
The total liver lipid was determined gravimetrically.8) Abbreviations: AAF, 2-acetylaminofluorene; PK, pyruvate kinase; GPD, a-glycerophosphate dehydrogenase. content were analyzed, the details of which were described in the previous paper.8)
Experiment 4: Effect of AAF on hepatic drugmetabolizing enzymes. The effect of AAFon the activity of drug-metabolizing enzymes in liver microsomes was investigated using rats fed on Diets I and III for 3 weeks, separately from Exp. 1. A liver microsomal fraction was prepared and the activity of/7-nitroanisol demethylase was assayed by measuring the formation of /?-nitrophenol according to Kato and Gillete.9) The activity of aniline hydroxylase was assayed by measuring the formation ofpaminophenol according to Schenkman et al.l0) Experiment 5: Effect ofAAF on hepatic pyruvate kinase {PK) and a-glycerophosphate dehydrogenase (GPD). The rats in Exp. 4 were used. In this experiment, the pairfeeding of Diet I for Diet III was also carried out to eliminate the effect of differing food intake on the enzyme activities.
The cytosolic fraction for an assay ofPK and GPDwas obtained by the following procedure. The liver was homogenized with 6 volumes of 0.25m sucrose in a PotterElvehjem homogenizer. The homogenates were centrifuged at 700 xg for lOmin and the supernatant fraction was centrifuged at 105,000 x g for 60min in an ultracentrifuge. The resultant supernatant solution was used for the enzyme assay. PK activity was determined by the 2,4-dinitrophenylhydrazine method, according to Kimberg et al.n) GPDactivity was determined by the initial change in optical density at 340nm due to the formation of NADH, according to Ziboh purchased from the Japan Radio-Isotope Association, Tokyo. The preparation of liver slices, the composition of the incubation medium, the condition of incubation, the separation of the lipid, and the counting of radioactivity of the lipid and CO2 were carried out as previously described. 13* Experiment 7: Effect of AAFon the transport of lipid from the liver. The rats fed on Diets I and III for 3 weeks, separately from Exp. 4, were used. At the end of an experimental period of 3 weeks, the rats were fasted for 8hr to avoid the effect of dietary fat on the plasma triglyceride level. The rats were lightly anesthetized with diethyl ether and injected intravenously into tail vein with Triton WR-1339 (0.3ml per lOOg body weight of a 15% solution of Triton WR-1339 in 0.95% NaCl).14) Triton WR-1339 was obtained from Nakarai Chemicals Ltd., Kyoto. After the injection of Triton, blood was drawn thrice at hourly intervals from the heart with a syringe under ether anesthesia. The plasma triglyceride and total cholesterol were determined as previously described.8) Experiment 8: Effect of adenine on AAF-induced fatty liver. Diets III (0.05% AAF) and V, which incorporated 0.25% adenine in the 0.05% AAFdiet at the expense of corn starch, were used. After feeding for 3 weeks, the rats were sacrificed and the total liver lipid was determined.
Statistical analysis. The results were tested by an analysis of variance, and Tukey's procedure for multiple comparisons wasused to evaluate the statistical significance with a probability level of 0.05.15) RESULTS 
AND DISCUSSION
Effect ofAAF dose on the liver lipid {Experiment 1) Growth curves of rats fed diets varying in Each point represents the mean ± SEM(vertical bar) for 5 rats. An asterisk indicates that the difference from control group is significant (/? <0.05).
-O-, Diet I (control); -#-, Diet III (0.05% AAF).
AAFdose are illustrated in Fig. 1 . The effect ofAAFdose on food intake, body weight gain and liver weight are shown in Table II . The administration of AAFcaused noticeable decreases in food intake, body weight gain and liver weight. The decrease in body weight was very likely the result of a reduced appetite. The decrease of liver weight, on the basis of 100g body weight, suggests that AAF does not cause the hepatomegaly. As shown in Table II, however, the liver lipid of rats fed on the 0.05% and 0.10% AAF diets was markedly increased. The livers in these groups were fatty to the naked eye. This induction of fatty liver bv AAF in the rat appears to be the first unequivocal demonstration.
Time course for the accumulation of liver lipid {Experiment 2)
As shown in Fig. 2 , the liver lipid of rats fed on the AAF diet increased gradually for 3 weeks and a significant difference from that of the control group was found in the third week. 
Analysis of liver lipid {Experiment 3)
The composition of liver lipids in rats fed on diets with and without AAFis shown in Table Table III 
Effect of AAFon hepatic drug-metabolizing enzymes (Experiment 4)
The effect of AAF on hepatic drugmetabolizing enzymes is presented in vivo the conversion of AAFto JV-hydroxy-AAF. In the present study, the effect of an oral administration of AAFon the activities ofpnitroanisol demethylase and aniline hydroxylase was investigated.
A similar conclusion to Astrom and DePierre16) may be drawn for the present study, although different substrates were used for the enzyme assays.
Effect of AAF on hepatic PK and GPD (Experiment 5) As shown in Table IV , both the activities of PK and GPD in the AAF group were markedly decreased to about 32% and 53%, respectively.
It has already been reported that these enzymes in the liver were under dietary regulation.18'1^Accordingly, it was unclear whether these reduced activities in the AAFgroup were due to the effect ofAAFper se or to the decreased food consumption. Therefore, the pair-feeding of Diet I for Diet III was carried out. The result of pair-feeding indicates that the reduced enzyme level by the AAFdiet is due mainly to the effect of AAFper se rather than to the decreased food consumption. Poirier et al.20) have reported that AAFfeeding caused a loss of metabolic response of glucokinase, glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, and citric cleavage enzyme to dietary induction by a 30% protein diet. Fischer and Grund21) have reported that the activity of PK induced by refeeding was lower in the animals fed on AAF. It seems that the results obtained from the present study are not contrary to their results. Wereported in the previous paper that (Specific activity x total liver lipid/body weight) x 100. dpm/lOOmg of liver slice. Mean±SEM 0=3). Each point represents the mean+SEM(vertical bar) for 5 rats. An asterisk indicates that the difference from each control group is significant (/? <0.05).
-O-> Diet I (control); -%-, Diet III (0.05% AAF).
GPD, which is responsible for producing the lipid was not significant, in terms of either the specific activity or total activity. These results suggest that the induction of this type of fatty liver is not due to the stimulation of hepatic lipogenesis. No significant difference in 14CO2-generation was also observed between the two groups. It is likely that the impairment of conversion of acetate to CO2, which has been assumed to be one of the causes of fatty liver induction, did not occur in this fatty liver.
Effect ofAAF on the transport oflipidfrom the liver {Experiment 7)
Changes of the plasma triglyceride and cholesterol in Triton-treated rats fed on diets with and without AAF are illustrated in Fig. 3 .
Triton WR-1339is known as an agent for producing massive hyperlipemia by preventing the removal of triglyceride from the plasma. The normal accumulation of triglyceride in the plasma following Triton treatment was markedly reduced in the AAF group, unlike the control group, indicating that the liver lipids did not enter the blood at their normal rate.
The changes of plasma cholesterol were not different between the two groups. This result suggests that a block in the secretion of triglyceride, probably due to the inhibition of plasma lipoprotein synthesis in the liver, is a major cause of the induction of this fatty liver.
A similar phenomenon was found by Effect of adenine on AAF-induced fatty liver {Experiment 8) As illustrated in Fig. 4 , the supplement of adenine to the AAFdiet had no effect on the accumulation of liver lipid.
Considerable evidence suggests that the fatty livers induced by several compounds such as ethionine, carbon tetrachloride, azaserine and orotic acid mayresult from an altered content of purine relative to pyrimidines in the liver. Support for this hypothesis comes from the reversibility of the fatty liver by the administration of adenine or adenosine triphosphate.26~28) Consequently, the effect of an adenine supplement on the accumulation of liver lipid by AAF was examined. From the result obtained, it is unlikely that the induction of fatty liver by AAFis involved in the disorder of adenine metabolism.
In the present study, we have found that a fatty liver in the rat is induced by the carcino- 
